Enisoprost
Alternative Names: SC 34301Latest Information Update: 08 Nov 1994
Price :
$50 *
At a glance
- Originator Pharmacia Corporation
- Class Antiulcers; Prostaglandins; Small molecules
- Mechanism of Action Immunosuppressants; Prostaglandin E1 agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Peptic ulcer; Transplant rejection
Most Recent Events
- 08 Nov 1994 Discontinued-III for Peptic ulcer in USA (PO)
- 08 Nov 1994 Discontinued-III for Transplant rejection in USA (PO)